Endothelial dysfunction is the hallmark feature in the development of early atherosclerotic lesions, and IL-33 has been reported to be involved in endothelial cell activation, leading to an exacerbation of inflammation [40]. The gene discussed is IL33; the disease is endothelial dysfunction.